The company is planning an NDA submission for the neuroendocrine tumour-targeting ITM-11 later in 2025.
Author: admin
Can taking semaglutide before bariatric surgery boost weight loss? Here’s what scientists found – The Times of India
Can taking semaglutide before bariatric surgery boost weight loss? Here’s what scientists found The Times of India
Recon: Judge bars compounders from making copies of Lilly’s weight loss drugs; PTAB invalidates two Moderna COVID vaccine patents – Regulatory Focus
Recon: Judge bars compounders from making copies of Lilly’s weight loss drugs; PTAB invalidates two Moderna…
You’ve Already Paid for Overpriced Weight-Loss Drugs – Jacobin magazine
You’ve Already Paid for Overpriced Weight-Loss Drugs Jacobin magazine
What chunky dogs and obese people have in common — and what it tells us about weight loss – New York Post
What chunky dogs and obese people have in common — and what it tells us about…
Novo Nordisk to explore how GLP-1 drugs can help patients with addiction – Reuters
Novo Nordisk to explore how GLP-1 drugs can help patients with addiction Reuters
Weight loss drug-makers are cutting prices – KSDK.com
Weight loss drug-makers are cutting prices KSDK.com
Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University – Business Wire
Allosteric Bioscience, Inc. Licenses Sarcopenia (Muscle Loss) Prevention/Treatment Technology from Johns Hopkins University Business Wire
Is Wegovy covered by Medicare? You may be able to get it, but only if you are in this specific situation – Marca English
Is Wegovy covered by Medicare? You may be able to get it, but only if you…
Project Optimus: The evolution of dose optimisation in oncology
Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As…